Evolution of the Average Target: Imexpharm Corporation

Evolution of the Average Target - Imexpharm Corporation

Evolution of the Target Price: Imexpharm Corporation

Evolution of the Target Price - Imexpharm Corporation

Changes in Analyst Recommendations: Imexpharm Corporation

c94d2a5660239b9e.79XbbHsJXIO8r8JHuqD1ilrFoH3Hy--sBKjjcDwXLnI.q4LiPjFZFrHbxpM-9OG3wxyjlS60v9bmUfi5BWtTZh3WtoocN0JqtITrpQ~534948dadf43d75c2fb87ad8554f7fe3

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - +59.54%
+1.47%
-0.49%
+5.7%
-1.34%
+9.1%
-5.5%
+16.05%
-7.63%
+2.28%
Average +7.92%
Weighted average by Cap. +2.06%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
35,100.00VND
Average target price
56,000.00VND
Spread / Average Target
+59.54%
High Price Target
56,000.00VND
Spread / Highest target
+59.54%
Low Price Target
56,000.00VND
Spread / Lowest Target
+59.54%

Analyst Consensus Detail

Analyst consensus - Imexpharm Corporation

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Imexpharm Corporation
  1. Stock Market
  2. Stocks
  3. IMP Stock
  4. Consensus Imexpharm Corporation